Medifast, Inc. (NYSE:MED) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. cut its stake in Medifast, Inc. (NYSE:MEDFree Report) by 81.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,104 shares of the specialty retailer’s stock after selling 65,203 shares during the quarter. Victory Capital Management Inc.’s holdings in Medifast were worth $1,131,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. BlackRock Inc. lifted its stake in Medifast by 6.9% in the 1st quarter. BlackRock Inc. now owns 2,134,513 shares of the specialty retailer’s stock worth $364,532,000 after purchasing an additional 138,602 shares in the last quarter. Vanguard Group Inc. lifted its stake in Medifast by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,521,936 shares of the specialty retailer’s stock worth $259,916,000 after purchasing an additional 22,630 shares in the last quarter. Renaissance Technologies LLC lifted its stake in Medifast by 4.5% in the 2nd quarter. Renaissance Technologies LLC now owns 680,610 shares of the specialty retailer’s stock worth $62,725,000 after purchasing an additional 29,600 shares in the last quarter. State Street Corp lifted its stake in Medifast by 0.5% in the 2nd quarter. State Street Corp now owns 381,761 shares of the specialty retailer’s stock worth $35,806,000 after purchasing an additional 1,803 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Medifast by 1.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 337,297 shares of the specialty retailer’s stock worth $31,085,000 after purchasing an additional 4,558 shares in the last quarter. 87.83% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Medifast from a “buy” rating to a “hold” rating in a report on Tuesday, November 7th.

Read Our Latest Research Report on MED

Medifast Stock Up 5.0 %

Shares of NYSE MED opened at $56.23 on Tuesday. The company has a 50 day simple moving average of $62.40 and a 200-day simple moving average of $72.39. The company has a market capitalization of $612.34 million, a P/E ratio of 5.13 and a beta of 1.22. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.04 and a quick ratio of 1.51. Medifast, Inc. has a 1 year low of $51.44 and a 1 year high of $115.95.

About Medifast

(Free Report)

Medifast, Inc, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.

Read More

Want to see what other hedge funds are holding MED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medifast, Inc. (NYSE:MEDFree Report).

Institutional Ownership by Quarter for Medifast (NYSE:MED)

Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter.